Growth study for children with idiopathic short stature
Part of Hormones & metabolism clinical trials.
This study tests whether an investigational drug can help children with idiopathic short stature (short height with no known cause) grow taller. It may be an option for children who are very short for their age and have not responded well to standard growth hormone therapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- The child must be between 2 and 14 years old (girls) or 2 and 16 years old (boys).
- The child's height must be very short (more than 2.25 standard deviations below average for their age and sex).
- The child can either have never received growth hormone treatment or be currently receiving it.
- A growth hormone stimulation test must have shown a level greater than 10 micrograms per liter.
- Parents or guardians must agree to sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing an experimental growth hormone treatment for children who are short for their age but otherwise healthy. Participation may help determine if the treatment can safely improve growth.
This trial tests a medication called vosoritide to see if it can help children with unexplained short stature grow taller. It's for kids who are very short for their age but have normal growth hormone levels and no other known cause.
This study tests a new growth hormone injection (Inpegsomatropin) to help children with idiopathic short stature (short stature with no known cause) grow taller. It may be an option if your child is very short compared to peers and has not started puberty.
This study follows children who are short for their age and checks how safe and effective growth hormone is over the long term. It may help families understand expected benefits and side effects for their specific growth-related condition.
This trial studies the long-term safety and effectiveness of Growtropin®-II, a growth hormone–type injection, in children who are short due to certain causes. It may help your child’s growth over time, while also closely tracking side effects.
This study tests different doses of a long-acting growth hormone medicine to see which works best for children who are shorter than expected for their age. It may help improve growth in both early and later stages of puberty.
Hear when a new Idiopathic Short Stature trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.